Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ingenia Therapeutics Inc

Clinical trials sponsored by Ingenia Therapeutics Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug IGT-303 tested for safety in kidney disease patients Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug IGT-303 tested for safety in kidney disease patients

Symptom relief Recruiting now

This study tests the safety of a new drug called IGT-303 in healthy volunteers and people with chronic kidney disease (CKD). About 94 participants will receive either the drug or a placebo, given as a shot under the skin or into a vein. Researchers will monitor for side effects t…

Phase 1/2 • Sponsor: Ingenia Therapeutics INC • Aim: Symptom relief

Last updated Jun 27, 2026 12:35 UTC